Arcellx (ACLX) Research & Development (2021 - 2025)

Arcellx (ACLX) recorded quarterly Research & Development of $34.1 million in Q4 2025, down 2.83% quarter-over-quarter from $35.1 million in Q3 2025, and down 23.64% on a YoY basis from $44.6 million in Q4 2024.

Arcellx (ACLX) Research & Development (2021 - 2025) Analysis & Trends

Arcellx's Research & Development history runs 5 years deep, the most recent figure standing at $34.1 million for Q4 2025.

  • In Q4 2025, Research & Development fell 23.64% year-over-year to $34.1 million; the TTM figure through Dec 2025 stood at $157.6 million (changed 0.33% YoY), while the FY2025 annual figure was $157.6 million, changed 0.33% from the prior year.
  • Research & Development was $34.1 million for Q4 2025 at Arcellx, down from $35.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $83.5 million in Q3 2022 to a low of $8.5 million in Q1 2021.
  • Historically, Research & Development has averaged $32.2 million across 5 years, with a median of $32.6 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Research & Development soared 577.27% in 2022, then slumped 47.52% in 2023.
  • A 5-year view of Research & Development shows it stood at $13.4 million in 2021, then jumped by 93.69% to $25.9 million in 2022, then climbed by 10.95% to $28.8 million in 2023, then soared by 55.12% to $44.6 million in 2024, then decreased by 23.64% to $34.1 million in 2025.
  • The last three Research & Development figures came in at $34.1 million (Q4 2025), $35.1 million (Q3 2025), and $37.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 34.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 34.10 Mn
Sep 30, 2025 35.09 Mn
Jun 30, 2025 37.63 Mn
Mar 31, 2025 50.80 Mn
Dec 31, 2024 44.65 Mn
Sep 30, 2024 39.17 Mn
Jun 30, 2024 40.95 Mn
Mar 31, 2024 32.32 Mn
Dec 31, 2023 28.78 Mn
Sep 30, 2023 43.81 Mn
Jun 30, 2023 28.33 Mn
Mar 31, 2023 32.93 Mn
Dec 31, 2022 25.94 Mn
Sep 30, 2022 83.47 Mn
Jun 30, 2022 22.08 Mn
Mar 31, 2022 18.06 Mn
Dec 31, 2021 13.39 Mn
Sep 30, 2021 12.33 Mn
Jun 30, 2021 12.64 Mn
Mar 31, 2021 8.52 Mn